SIC 2833 – Medicinal Chemicals and Botanical Products
| Valuation | |
|---|---|
| Market Cap ($M) | 394.05 |
| Enterprise Value ($M) | n/a |
| Book Value ($M) | 509.67 |
| Book Value / Share | 4.84 |
| Price / Book | n/a |
| NCAV ($M) | -331.01 |
| NCAV / Share | -3.14 |
| Price / NCAV | n/a |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.50 |
| Return on Assets (ROA) | -0.34 |
| Return on Equity (ROE) | -0.75 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 1.07 |
| Current Ratio | 1.39 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 391.67 |
| Assets | 1,232.35 |
| Liabilities | 722.68 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 297.15 |
| Operating Income | -128.95 |
| Net Income | -657.27 |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -281.95 |
| Cash from Investing | 241.59 |
| Cash from Financing | -465.06 |
(click for more detail) |
|
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 1,065,029 | 3,675,209 | 28.98 | |
| 1,502,372 | 5,007,140 | 30.00 | |
| 2,901,484 | 9,740,192 | 29.79 | |
| 4,101,972 | 13,410,615 | 30.59 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| BPMC – Blueprint Medicines Corporation | CABA – Cabaletta Bio, Inc. |
| CCCC – C4 Therapeutics, Inc. | CGEM – Cullinan Therapeutics, Inc. |
| CGON – CG Oncology, Inc. |